PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2024/73 - Diaverum / Nefropinhal
Acquiring
Diaverum - Investimentos e Serviços, Lda
Description
Portuguese subsidiary of a Swedish multinational business group, whose activity focuses on renal care, offering a wide variety of dialysis services and renal disease support in more than 20 countries.
Acquired
Nefropinhal - Clinica Privada Sertã, Lda
Description
Company that has the activity of providing hemodialysis services, having a dialysis unit located in Sertã.
Sector
  • Health & Pharmaceutical
Activity (NACE)
  • Q8622 - Specialist medical practice activities
Applicable legislation
Art. 37(1)(a) (Law 19)
Notification thresholds
Market Share threshold
Type of merger
Conglomerate
Cooperation with sector regulators
  • ERS - Health Regulatory Entity
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

The merger operation consists of the acquisition by Diaverum - Investments and Services LDA. (“Diaverum”) of exclusive control over nephropinal - private clinic of Sertã, LDA. (“Nephropinal”).
Timeline
2024-11-28
The AdC issued a non-opposition decision to the merger 73/2024 - Diaverum / Nefropinhal.
2024-11-07
Diaverum notifies the acquisition of exclusive control over Nefropinhal.
Click here to see your activities